Skip to main content

Vrajesh K. Pandya, PhD

Languages spoken: English

Academic Information

Departments: Pathology - Assistant Professor (Clinical)

Divisions: Clinical Pathology

Academic Office Information

Board Certification

  • American Board of Clinical Chemistry (Sub: Clinical Chemistry)

Education History

Postdoctoral Fellowship University of Utah School of Medicine
Clinical Chemistry
Postdoctoral Fellow
Postdoctoral Fellowship University of Alberta
Postdoctoral Fellow
Graduate Training University of Alberta
Graduate Training Maharaja Sayajirao University of Baroda
Undergraduate Gujarat University

Selected Publications

  1. Pandya V, Wilker C, Johnson-Davis KL (2023). Longitudinal trends in meconium drug detection in 46 US states between the years 2015-2020. J Anal Toxicol.
  2. Pandya V, McMillin GA, Young BA (2022). Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing? J Appl Lab Med, 8(2), 341-346.
  3. Pandya V (2022). Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation. Clin Chem, 69(3), 226-227.
  4. Pandya V, Wilker C, McMillin GA (2021). Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters. J Anal Toxicol, 47(1), 96-105.
  5. Pandya V, Frank EL (2022). A Simple, Fast, and Reliable LC-MS/MS Method for the Measurement of Homovanillic Acid and Vanillylmandelic Acid in Urine Specimens. Methods Mol Biol, 2546, 175-183.
  6. Pandya V, Hunsaker JJH, Laulu SL, Genzen JR, Frank EL, Johnson LM, Rudolf JW (2021). Excessively low cholesterol and triglyceride levels in an apparently healthy patient. Clin Biochem, 96, 78-81.
  7. Salla M, Pandya V, Bhullar KS, Kerek E, Wong YF, Losch R, Ou J, Aldawsari FS, Velazquez-Martinez C, Thiesen A, Dyck JRB, Hubbard BP, Baksh S (2020). Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs. Molecules, 25(17).
  8. Pandya V, Glubrecht D, Vos L, Hanson J, Damaraju S, Mackey J, Hugh J, Goping IS (2016). The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer. Oncotarget, 7(22), 33272-85.